Home > Insider Trading > Filing (0001035267-17-000151)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1035267	Intuitive Surgical Inc	ISRG	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	770416458

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1280627	J Alan Levy	1020 Kifer Road Sunnyvale CA 94086		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-10-24	936	$123.77	7,575	No	4	M	Direct
Common Stock	Disposition	2017-10-24	936	$371.35	6,639	No	4	S	Direct
Common Stock	Acquisiton	2017-10-24	2,061	$119.06	8,700	No	4	M	Direct
Common Stock	Disposition	2017-10-24	2,061	$371.35	6,639	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2017-10-24	2,061	$0.00	2,061	$119.06
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2017-10-24	936	$0.00	936	$123.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-04-21	No	4	M	Direct
0		2024-04-24	No	4	M	Direct

Footnotes

On October 6, 2017, the common stock and equity grants of Intuitive Surgical split 3-for-1, resulting in the reporting person's ownership of the company's stock and equity grants to increase (for every one share owned or granted, 2 additional shares were issued) and the exercise price of stock option grants to decrease to 1/3rd of the original grant price.
These shares were sold pursuant to a Rule 10b5-1 Trading Plan, entered into on November 29, 2016.
Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.